All stories tagged :

Pr Newswire

Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and...

admin
Pr Newswire

TheLotter Australia expands its offerings with the launch of a new...

admin
Pr Newswire

Bridge Biotherapeutics Announces Completion of Enrollment in the Phase 2a Clinical...

admin
Pr Newswire

DapuStor Extends Collaboration with Marvell to Unveil Cutting-Edge Flexible Data Placement...

admin
Pr Newswire

Nature’s Miracle Holding Inc. Announces Closing of $1.2 Million Public Offering

admin
Pr Newswire

Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S.,...

admin
Pr Newswire

iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered...

admin
Pr Newswire

Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference

admin
Pr Newswire

MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results...

admin
Pr Newswire

Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral...

admin
Pr Newswire

Pan Pacific Hotels Group Extends Presence in Japan through Continued Strategic...

admin

Featured

Pr Newswire

Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and...

admin
Pr Newswire

Luma Nutrition Magnesium Glycinate Surpasses 10,000 Monthly Sales on Amazon

admin
Pr Newswire

Aerolib Healthcare Solutions Unveils Aerolib AI: The Ultimate Appeals Machine

admin
Pr Newswire

Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International...

admin
admin

Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and...

ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced the appointments of Veet Misra, Ph.D., as the Company’s Chief...